U.S. District Judge Kenneth Bell, who is overseeing the Gardasil multidistrict litigation in the Western District of North Carolina, sided with Merck on its implied preemption defense, granting ...
New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A global health care company is growing its footprint in North Carolina ...
The $1 billion plant will manufacture the HPV vaccines Gardasil and Gardasil 9, while the site continues to produce vaccines against measles, mumps, rubella, and chickenpox, among other illnesses ...
Gardasil and Gardasil 9 are together Merck's second best-selling product, with global sales of $8.58 billion in 2024. U.S. patent protection expires in 2028. The U.S. Centers for Disease Control ...
In what’s shaping up to be a red-letter week for Gardasil, Merck & Co. has simultaneously opened a massive new manufacturing facility for the human papillomavirus (HPV) shot in the U.S. and put ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results